1186 related articles for article (PubMed ID: 19375895)
1. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris.
Caillon F; O'Connell M; Eady EA; Jenkins GR; Cove JH; Layton AM; Mountford AP
Br J Dermatol; 2010 Feb; 162(2):296-303. PubMed ID: 19796181
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
Basal E; Jain A; Kaushal GP
J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
[TBL] [Abstract][Full Text] [Related]
4. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
Kuwahara K; Kitazawa T; Kitagaki H; Tsukamoto T; Kikuchi M
J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123
[TBL] [Abstract][Full Text] [Related]
5. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
Załuga E
Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
[TBL] [Abstract][Full Text] [Related]
6. Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes.
Wilcox HE; Farrar MD; Cunliffe WJ; Holland KT; Ingham E
Br J Dermatol; 2007 Mar; 156(3):460-5. PubMed ID: 17300234
[TBL] [Abstract][Full Text] [Related]
7. Evidence for diversity within Propionibacterium acnes: a comparison of the T-cell stimulatory activity of isolates from inflammatory acne, endocarditis and the laboratory.
Jappe U; Boit R; Farrar MD; Ingham E; Sandoe J; Holland KT
J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):450-4. PubMed ID: 15196160
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory properties of a new undecyl-rhamnoside (APRC11) against P. acnes.
Isard O; Lévêque M; Knol AC; Ariès MF; Khammari A; Nguyen JM; Castex-Rizzi N; Dréno B
Arch Dermatol Res; 2011 Dec; 303(10):707-13. PubMed ID: 21461892
[TBL] [Abstract][Full Text] [Related]
9. Quantitative PCR of Propionibacterium acnes DNA in samples aspirated from sebaceous follicles on the normal skin of subjects with or without acne.
Miura Y; Ishige I; Soejima N; Suzuki Y; Uchida K; Kawana S; Eishi Y
J Med Dent Sci; 2010 Mar; 57(1):65-74. PubMed ID: 20437767
[TBL] [Abstract][Full Text] [Related]
10. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.
Kim J
Dermatology; 2005; 211(3):193-8. PubMed ID: 16205063
[TBL] [Abstract][Full Text] [Related]
11. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients.
Kistowska M; Meier B; Proust T; Feldmeyer L; Cozzio A; Kuendig T; Contassot E; French LE
J Invest Dermatol; 2015 Jan; 135(1):110-118. PubMed ID: 25010142
[TBL] [Abstract][Full Text] [Related]
12. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III.
Schaller M; Loewenstein M; Borelli C; Jacob K; Vogeser M; Burgdorf WH; Plewig G
Br J Dermatol; 2005 Jul; 153(1):66-71. PubMed ID: 16029328
[TBL] [Abstract][Full Text] [Related]
13. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
Popovic S; Urbán E; Lukic M; Conlon JM
Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
[TBL] [Abstract][Full Text] [Related]
14. Acne: inflammation.
Farrar MD; Ingham E
Clin Dermatol; 2004; 22(5):380-4. PubMed ID: 15556722
[TBL] [Abstract][Full Text] [Related]
15. Temporal changes in sebum excretion and propionibacterial colonization in preadolescent children with and without acne.
Mourelatos K; Eady EA; Cunliffe WJ; Clark SM; Cove JH
Br J Dermatol; 2007 Jan; 156(1):22-31. PubMed ID: 17199562
[TBL] [Abstract][Full Text] [Related]
16. Induction of toll-like receptors by Propionibacterium acnes.
Jugeau S; Tenaud I; Knol AC; Jarrousse V; Quereux G; Khammari A; Dreno B
Br J Dermatol; 2005 Dec; 153(6):1105-13. PubMed ID: 16307644
[TBL] [Abstract][Full Text] [Related]
17. Neuraminidase production by Propionibacterium acnes-strains isolated from patients with acne vulgaris, seborrheic eczema and healthy subjects.
Höffler U; Gloor M; von Nicolai H
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):122-6. PubMed ID: 6458977
[TBL] [Abstract][Full Text] [Related]
18. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne.
Białecka A; Mak M; Biedroń R; Bobek M; Kasprowicz A; Marcinkiewicz J
Arch Immunol Ther Exp (Warsz); 2005; 53(1):79-85. PubMed ID: 15761379
[TBL] [Abstract][Full Text] [Related]
19. "SAPHO syndrome and infections".
Govoni M; Colina M; Massara A; Trotta F
Autoimmun Rev; 2009 Jan; 8(3):256-9. PubMed ID: 18721907
[TBL] [Abstract][Full Text] [Related]
20. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies.
Dessinioti C; Katsambas AD
Clin Dermatol; 2010; 28(1):2-7. PubMed ID: 20082942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
